Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,3611,380 of 20,252 grants

Active NON-SBIR/STTR RPGS
Pathology Core
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT The Pathology Core will be co-led by Dr. Marisa Nucci, a pathologist with expertise in gynecologic neoplasia, and by Dr. Geoffrey Shapiro, who brings exper...

Completed NON-SBIR/STTR RPGS
Mapping ductal carcinoma in situ in space and time to reveal biomarkers that can predict invasive risk
NATIONAL CANCER INSTITUTE Flanders Interuniv Inst Biotechnology BELGIUM 2024 – 2026

ABSTRACT Each year, 50.000 women are diagnosed with ductal carcinoma in situ (DCIS) in the US. DCIS is a non-invasive form of breast cancer, which respects the natural tissue barri...

$1.32M
USD
Completed NON-SBIR/STTR RPGS
Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection
NATIONAL CANCER INSTITUTE University of Arkansas for Med Scis United States 2024 – 2026

Abstract Ovarian cancer remains the most lethal gynecological malignancy due to the lack of highly sensitive and specific screening tools for detection of early-stage disease. The...

$4.12M
USD
Active NON-SBIR/STTR RPGS
Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosis
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2028

SUMMARY Obesity increases the risk of numerous cancers including colorectal cancer (CRC). With the growing global epidemic of obesity, a greater understanding of the obesity cancer...

$7.24M
USD
Active NON-SBIR/STTR RPGS
Regulation of RBP Function during EMT
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2024 – 2029

The goal of this research is to characterize Ras-driven and KSR1-dependent mechanisms that modulate tumor initiation, drug resistance and the epithelial-to-mesenchymal transition (...

$4.34M
USD
Active NON-SBIR/STTR RPGS
Bioreactor for Manufacturing Chemotactically Competent Immune Cell Therapies
NATIONAL CANCER INSTITUTE Sri International United States 2024 – 2027

PROJECT SUMMARY Current cell expansion procedures for antigen-specific CAR T cells and CAR NK cells result in cells with a broad repertoire of chemokine receptors. Upon infusion, t...

$3.75M
USD
Completed SBIR-STTR RPGS
Development of IFNA2-LNP01 for tumor lung metastases immunotherapy
NATIONAL CANCER INSTITUTE Chemedimmune, Inc United States 2024 – 2025

Project Summary Lung metastasis is the 2nd most common metastasis and accounts for 30% of all metastatic diseases in human cancer patients. Patients with lung metastases have a ver...

$3.21M
USD
Active TRAINING, INDIVIDUAL
Chromosomal Instability and 17p Loss Sensitize Cancer Cells to NDE1 Depletion
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2027

PROJECT SUMMARY Chromosomal Instability (CIN) and loss of the short arm of chromosome 17 (17p) are interrelated and relatively common characteristics of many advanced, metastatic c...

$482.9K
USD
Completed SBIR-STTR RPGS
Engager T cell: A Simple Solution for Off-the-shelf T Cell Therapy for Cancer
NATIONAL CANCER INSTITUTE Immunebro Therapeutics Inc United States 2024 – 2025

Project Summary Autologous chimeric antigen receptor T (CAR T) cell therapy poses logistical and economical challenges despite curative potential. Donor-derived allogeneic off-the-...

$3.62M
USD
Completed SBIR-STTR RPGS
A novel MICA/B based tumor-centric bispecific antibody that enhances NK cell activity in a hostile tumor microenvironment
NATIONAL CANCER INSTITUTE Aakha Biologics Inc United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT Problem: Lung cancer is the third most common cancer in the US, with an estimated 238,340 new cases in 2023, and is projected to be about 2.5 times more de...

$4M
USD
Completed SBIR-STTR RPGS
High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures
NATIONAL CANCER INSTITUTE Celldom, Inc United States 2024 – 2026

ABSTRACT Over the last decade, cell based “living medicines” like chimeric antigen receptor (CAR)-T cell immunotherapies have led to miraculous cures in advanced and aggressive leu...

$9.39M
USD
Active SBIR-STTR RPGS
Computer Guided Microwave Liver Ablation
NATIONAL CANCER INSTITUTE Ne Scientific, Llc United States 2024 – 2027

Project Summary: The primary objective of this proposed research program is to evaluate in a clinical trial the improvements to clinical outcomes that the use of a software for sup...

$6.03M
USD
Active TRAINING, INDIVIDUAL
Defining the functional and spatial properties of tumor-specific tumor-infiltrating CD8 T cells
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2024 – 2027

Project Summary/Abstract Successful anti-tumor immune response requires coordination between the arms of immunity against multiple tumor antigens, as shown through studies of anima...

$432K
USD
Active TRAINING, INDIVIDUAL
Predicting prostate cancer clinical outcomes with germline genomic biomarkers
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT Prostate cancer is the second-most diagnosed cancer and the second leading cause of cancer death in American men. Early detection of localized disease is c...

$413.3K
USD
Completed TRAINING, INDIVIDUAL
Accurate interaction detection in combinatorial screens with complex phenotypes
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2026

Project Summary Combinatorial screens characterize the molecular pathways of the cell by identifying interactions between perturbations. Quantifying interactions requires a notion...

$414.9K
USD
Active NON-SBIR/STTR RPGS
Targeting WEE1 in uterine serous or p53-mutated uterine cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT: PROJECT 1 – WEE1 inhibition in uterine serous carcinomas or p53-mutated uterine cancers Uterine serous carcinomas (USC) are a distinct histologic subtype...

Active NON-SBIR/STTR RPGS
Targeting replication stress to engage DNA sensing STING pathway derived anti-tumor immunity to improve the therapeutic outcomes in uterine cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

Project Summary Microsatellite stable (MSS)/mismatch repair proficient (MMRP) uterine cancers (UCs) represent approximately two thirds (66%) of all UCs in The Cancer Genome Atlas (...

Active NON-SBIR/STTR RPGS
Administrative Core
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

Project Summary The Administrative Core is led by Drs. Panagiotis Konstantinopoulos, Joyce Liu, and Ursula Matulonis who are in addition the Principal Investigators (PI)/Program Di...

Active NON-SBIR/STTR RPGS
Dissecting roles of Lunatic Fringe-dependent Notch signaling in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Mississippi Med Ctr United States 2024 – 2029

Despite improvements in overall survival for most cancers, survival for patients with pancreatic cancer remains dismally low due to the late diagnosis and rapid spreading. Understa...

$3.55M
USD
Active NON-SBIR/STTR RPGS
Trajectory of epigenetic aging and health outcomes in childhood cancer survivors
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2024 – 2029

ABSTRACT Survivors of childhood cancer are at increased risk for chronic health conditions (CHCs) and early mortality at rates typically among individuals decades older, suggesting...

$7.54M
USD